"Parkinsonian Disorders" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A group of disorders which feature impaired motor control characterized by bradykinesia, MUSCLE RIGIDITY; TREMOR; and postural instability. Parkinsonian diseases are generally divided into primary parkinsonism (see PARKINSON DISEASE), secondary parkinsonism (see PARKINSON DISEASE, SECONDARY) and inherited forms. These conditions are associated with dysfunction of dopaminergic or closely related motor integration neuronal pathways in the BASAL GANGLIA.
| Descriptor ID |
D020734
|
| MeSH Number(s) |
C10.228.140.079.862 C10.228.662.600
|
| Concept/Terms |
Parkinsonian Disorders- Parkinsonian Disorders
- Parkinsonian Syndrome
- Parkinsonism
- Parkinsonian Syndromes
- Parkinsonian Diseases
Autosomal Recessive Juvenile Parkinson Disease- Autosomal Recessive Juvenile Parkinson Disease
- Chromosome 6-Linked Autosomal Recessive Parkinsonism
- Chromosome 6 Linked Autosomal Recessive Parkinsonism
- Familial Parkinson Disease, Autosomal Recessive
- Juvenile Parkinson Disease, Autosomal Recessive
- Juvenile Parkinsonism, Autosomal Recessive
- Parkinsonism, Early Onset, with Diurnal Fluctuation
- Parkinsonism, Juvenile, Autosomal Recessive
- Parkinson Disease 2, Autosomal Recessive Juvenile
- Parkinsonism, Early-Onset, With Diurnal Fluctuation
- Parkinson Disease, Juvenile, Autosomal Recessive
- Parkinson Disease 2
- Parkinson Disease Autosomal Recessive, Early Onset
- Autosomal Recesssive Juvenile Parkinsonism
- Parkinson Disease, Familial, Autosomal Recessive
Parkinsonism, Experimental- Parkinsonism, Experimental
- Experimental Parkinsonisms
- Parkinsonisms, Experimental
- Parkinson Disease, Experimental
- Experimental Parkinsonism, MPTP-Induced
- Experimental Parkinsonism, MPTP Induced
- Parkinsonism, MPTP-Induced Experimental
- MPTP-Induced Experimental Parkinsonism
- MPTP Induced Experimental Parkinsonism
- Experimental Parkinson Disease
- Diseases, Experimental Parkinson
- Experimental Parkinson Diseases
- Parkinson Diseases, Experimental
- Experimental Parkinsonism
Parkinsonism, Juvenile- Parkinsonism, Juvenile
- Juvenile Parkinsonism
- Juvenile Parkinsonisms
- Parkinsonisms, Juvenile
- Parkinson Disease, Juvenile
- Juvenile Parkinson Disease
Autosomal Dominant Juvenile Parkinson Disease- Autosomal Dominant Juvenile Parkinson Disease
- Juvenile Parkinson Disease, Autosomal Dominant
- Parkinsonism, Juvenile, Autosomal Dominant
- Parkinson Disease, Autosomal Dominant. Juvenile
- Parkinson Disease, Juvenile, Autosomal Dominant
- Autosomal Dominant Juvenile Parkinsonism
- Juvenile Parkinsonism, Autosomal Dominant
|
Below are MeSH descriptors whose meaning is more general than "Parkinsonian Disorders".
Below are MeSH descriptors whose meaning is more specific than "Parkinsonian Disorders".
This graph shows the total number of publications written about "Parkinsonian Disorders" by people in this website by year, and whether "Parkinsonian Disorders" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2000 | 1 | 0 | 1 |
| 2002 | 1 | 0 | 1 |
| 2004 | 1 | 0 | 1 |
| 2006 | 2 | 0 | 2 |
| 2007 | 1 | 0 | 1 |
| 2008 | 2 | 1 | 3 |
| 2009 | 1 | 0 | 1 |
| 2011 | 1 | 0 | 1 |
| 2012 | 2 | 0 | 2 |
| 2013 | 1 | 0 | 1 |
| 2014 | 1 | 0 | 1 |
| 2015 | 2 | 0 | 2 |
| 2016 | 3 | 0 | 3 |
| 2017 | 1 | 0 | 1 |
| 2020 | 2 | 0 | 2 |
| 2022 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Parkinsonian Disorders" by people in Profiles.
-
Dementia with Lewy bodies: Impact of co-pathologies and implications for clinical trial design. Alzheimers Dement. 2023 01; 19(1):318-332.
-
Differential effects of vagus nerve stimulation paradigms guide clinical development for Parkinson's disease. Brain Stimul. 2020 Sep - Oct; 13(5):1323-1332.
-
Calpain mediated expansion of CD4+ cytotoxic T cells in rodent models of Parkinson's disease. Exp Neurol. 2020 08; 330:113315.
-
Vagus nerve stimulation improves locomotion and neuronal populations in a model of Parkinson's disease. Brain Stimul. 2017 Nov - Dec; 10(6):1045-1054.
-
Rapidly progressive primary progressive aphasia and parkinsonism with novel GRN mutation. Mov Disord. 2017 03; 32(3):476-478.
-
Altered glutamate release in the dorsal striatum of the MitoPark mouse model of Parkinson's disease. Brain Res. 2016 11 15; 1651:88-94.
-
Distinct Nrf2 Signaling Mechanisms of Fumaric Acid Esters and Their Role in Neuroprotection against 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Induced Experimental Parkinson's-Like Disease. J Neurosci. 2016 06 08; 36(23):6332-51.
-
Severely impaired hippocampal neurogenesis associates with an early serotonergic deficit in a BAC a-synuclein transgenic rat model of Parkinson's disease. Neurobiol Dis. 2016 Jan; 85:206-217.
-
Inhibition of Calpain Activation Protects MPTP-Induced Nigral and Spinal Cord Neurodegeneration, Reduces Inflammation, and Improves Gait Dynamics in Mice. Mol Neurobiol. 2015 Oct; 52(2):1054-66.
-
An ?8F-FDG PET study of cervical muscle in parkinsonian anterocollis. J Neurol Sci. 2014 May 15; 340(1-2):174-7.